Author:
Chen Yu-Lun,Yang Tsung-Ying,Chen Kun-Chieh,Wu Chieh-Liang,Hsu Shih-Lan,Hsueh Chi-Mei
Funder
Taichung Veterans General Hospital, Ministry of Science and Technology, and Ministry of Education, Taiwan, ROC
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Molecular Medicine,General Medicine
Reference45 articles.
1. D. C. Ihde, J. D. Minna, Non-small cell lung cancer. Part II: Treatment Curr. Probl. Cancer 15, 105–154 (1991)
2. M. M. Gottesman, T. Fojo, S. E. Bates, Multidrug resistance in cancer: role of ATP-dependent transporters. Nat. Rev. Cancer 2, 48–58 (2002)
3. C. Zeng, W. Fan, X. Zhang, RRM1 expression is associated with the outcome of gemcitabine-based treatment of non-small cell lung cancer patients–a short report. Cell. Oncol. 38, 319–325 (2015)
4. P. D'Arpa, L. F. Liu, Topoisomerase-targeting antitumor drugs. Biochim. Biophys. Acta 989, 163–177 (1989)
5. L. A. Zwelling, S. Michaels, L. C. Erickson, R. S. Ungerleider, M. Nichols, K. W. Kohn, Protein-associated deoxyribonucleic acid strand breaks in L1210 cells treated with the deoxyribonucleic acid intercalating agents 4’-(9-acridinylamino) methanesulfon-m-anisidide and adriamycin. Biochemistry 20, 6553–6563 (1981)
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献